IBDEI14C ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19739,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,19739,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,19739,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,19740,0)
 ;;=V17.3^^105^1235^16
 ;;^UTILITY(U,$J,358.3,19740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19740,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,19740,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,19740,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,19741,0)
 ;;=V16.6^^105^1235^17
 ;;^UTILITY(U,$J,358.3,19741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19741,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,19741,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,19741,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,19742,0)
 ;;=V18.61^^105^1235^19
 ;;^UTILITY(U,$J,358.3,19742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19742,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,19742,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,19742,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,19743,0)
 ;;=V17.0^^105^1235^20
 ;;^UTILITY(U,$J,358.3,19743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19743,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,19743,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,19743,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,19744,0)
 ;;=V19.4^^105^1235^21
 ;;^UTILITY(U,$J,358.3,19744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19744,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,19744,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,19744,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,19745,0)
 ;;=V17.1^^105^1235^22
 ;;^UTILITY(U,$J,358.3,19745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19745,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,19745,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,19745,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,19746,0)
 ;;=V16.8^^105^1235^12
 ;;^UTILITY(U,$J,358.3,19746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19746,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,19746,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,19746,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,19747,0)
 ;;=V11.1^^105^1235^24
 ;;^UTILITY(U,$J,358.3,19747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19747,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,19747,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,19747,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,19748,0)
 ;;=V15.89^^105^1235^46
 ;;^UTILITY(U,$J,358.3,19748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19748,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,19748,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,19748,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,19749,0)
 ;;=V11.3^^105^1235^25
 ;;^UTILITY(U,$J,358.3,19749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19749,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,19749,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,19749,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,19750,0)
 ;;=V15.07^^105^1235^26
 ;;^UTILITY(U,$J,358.3,19750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19750,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,19750,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,19750,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,19751,0)
 ;;=V13.4^^105^1235^27
 ;;^UTILITY(U,$J,358.3,19751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19751,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,19751,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,19751,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,19752,0)
 ;;=V12.72^^105^1235^31
 ;;^UTILITY(U,$J,358.3,19752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19752,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,19752,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;
 ;;$END ROU IBDEI14C
